HOME >> MEDICINE >> NEWS
Clinical trial demonstrates that bone marrow transplant followed by vitamin A-derivative treatment improves survival from a major childhood cancer

Combining the efforts of children's cancer treatment programs nationwide, a randomized clinical trial of 539 children has shown that two innovative treatments, taken together, offer nearly a three-fold improvement in the disease-free survival of children with high-risk neuroblastoma, the third most common - and one of the most deadly -- of childhood cancers.

The National Cancer Institute-sponsored study showed that these children have the best chance of disease-free survival if their initial chemotherapy and surgery is followed by high-dose chemoradiotherapy and an autologous bone marrow transplant, where a child is re-implanted with her own bone marrow after it has been cleared of cancer cells. The results are improved even further if this treatment is followed by a high-dose course of 13-cis retinoic acid, a derivative of Vitamin A that also is prescribed for acne.

The study was led by Katherine K. Matthay, M.D., professor of pediatrics at the University of California, San Francisco and director of pediatric clinical oncology for Lucile Packard Children's Health Services at UCSF. The retinoic acid portion of the trial was led by C. Patrick Reynolds, M.D., Ph.D., of Childrens Hospital Los Angeles (CHLA), associate professor of pediatrics and pathology at the University of Southern California School of Medicine. Their results were reported in the October 14, 1999 issue of the New England Journal of Medicine.

The randomized multi-center Phase III clinical trial was the only way to prove the worth of these two treatments, which had shown promise in pilot studies, according to Matthay. "Studies had been done of bone marrow transplant, and of intensive chemotherapy. There were advocates of both treatments. But no one had done a randomized study of the two in comparison," she said.

Matthay credits the Children's Cancer Group, a national cooperative research organization, for enlisting the help of more than 100 cancer centers nationwide to join the stu
'"/>

Contact: Janet Basu
jbasu@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
14-Oct-1999


Page: 1 2 3 4

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... ... February 14, 2020 , ... Cloudticity announced today ... the company’s support for healthcare organizations using Amazon Web Services (AWS). , “Our ... or experience to do so,” explained Cloudticity Founder & CEO, Gerry Miller. “In ...
(Date:2/13/2020)... (PRWEB) , ... February 13, 2020 , ... ... seven locations in Northern Virginia: Arlington, Dulles-Aldie, Fair Oaks, Fairfax, Fredericksburg, Leesburg, and ... that eight D.C.- and Virginia-based fertility specialists have been named as Top Docs ...
(Date:2/11/2020)... ... 2020 , ... Soterius, Inc., a global provider of cutting-edge ... new, significantly larger business premises in Lawrenceville, NJ. The move supports the requirements ... digital technology platforms. , “As our customer base and offerings continue to grow, ...
(Date:2/10/2020)... ... , ... A January 26 article on Live Science reports on ... that – not unlike the skin’s response to dangerous conditions like extreme heat or ... to potential damage being done and warn the individual to escape the situation. Pasadena-based ...
(Date:2/10/2020)... Md. (PRWEB) , ... February 10, 2020 , ... ... the Public Health and Epidemiology Practice, has been elected president of the ... Group where she and her team develop and implement award-winning, research-driven Federal social ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... ... February 14, 2020 , ... The creators of Dullo Plus - ... relaxing sleep experience—are excited to announce the launch of a Kickstarter campaign for 35 ... types of pillows over the last four years. Dullo Plus is their most advanced ...
(Date:2/14/2020)... (PRWEB) , ... February 14, 2020 , ... ... donation of $55,496 to Children’s Healthcare of Atlanta (Children’s) raised through their annual ... a portion of all new or pre-owned vehicle sales between November 29, 2019, ...
(Date:2/13/2020)... Va. (PRWEB) , ... February 13, 2020 , ... The ... is up 2.9% from the estimated value of $93.9 billion in 2010, according to ... market. , “Growth in this market is driven by an aging ...
Breaking Medicine Technology:
Cached News: